Search by Drug Name or NDC

    NDC 66302-0664-03 Tyvaso DPI 64 ug/1 Details

    Tyvaso DPI 64 ug/1

    Tyvaso DPI is a ORAL INHALANT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by United Therapeutics Corporation. The primary component is TREPROSTINIL.

    Product Information

    NDC 66302-0664
    Product ID 66302-664_194fcd42-22c2-4f1b-a45a-02e2bbeeba6a
    Associated GPIs 40170080002950
    GCN Sequence Number 083422
    GCN Sequence Number Description treprostinil CART INHAL 64 MCG INHALATION
    HIC3 B1C
    HIC3 Description PULMONARY ANTIHYPERTENSIVES, PROSTACYCLIN-TYPE
    GCN 52378
    HICL Sequence Number 036541
    HICL Sequence Number Description TREPROSTINIL
    Brand/Generic Brand
    Proprietary Name Tyvaso DPI
    Proprietary Name Suffix n/a
    Non-Proprietary Name treprostinil
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INHALANT
    Route ORAL
    Active Ingredient Strength 64
    Active Ingredient Units ug/1
    Substance Name TREPROSTINIL
    Labeler Name United Therapeutics Corporation
    Pharmaceutical Class Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA214324
    Listing Certified Through 2024-12-31

    Package

    NDC 66302-0664-03 (66302066403)

    NDC Package Code 66302-664-03
    Billing NDC 66302066403
    Package 4 BLISTER PACK in 1 KIT (66302-664-03) / 7 BLISTER PACK in 1 BLISTER PACK / 4 INHALANT in 1 BLISTER PACK
    Marketing Start Date 2022-05-23
    NDC Exclude Flag N
    Pricing Information N/A